•********* Kim, **** Kook, ****** Ma, ***** Lee, ********* Ko, ********* Kim, ******* Lee, ********* Lee, ******* Lee, ********* Kim, ******** Lee, ******** Jang. The novel psychoactive substance 25E-NBOMe induces reward-related behaviors via dopamine D1 receptor signaling in male rodents. 2024 Apr;47(4):360-376. (IF: 6.898)
•김**. 프랑스 형사 증거법상 증거사용의 허용과 배제. 2024 Apr 30;26(1)35-73. (IF: 1.37)
•****** Gupta, ****** Haldhar, ***** Agarwal, *************** Rajput, ******** Chun, ******** Han, ***** Raj, ******* Lee. Exploring the Potential of Natural Products as FoxO1 Inhibitors: an In Silico Approach. 2024 May 1;32(3):390-398. (IF: 3.0)
•****** Basyal, ******* Lee, ****** Kim. Antioxidants and Mechanistic Insights for Managing Dry Age-Related Macular Degeneration. 2024 May 4;13(5):568. (IF: 5.965)
•******* Kunala, ******* Tang, ************** Johnson, ****** Huynh, ***** Parkins, ****** Kim, ***** Yang, ****** Sparrow, ********* Hunter. Near Infrared Autofluorescence Lifetime Imaging of Human Retinal Pigment Epithelium Using Adaptive Optics Scanning Light Ophthalmoscopy. 2024 May 1;65(5):27. (IF: 5.0)
•****** Park, ***** Kim. Neural network approach to predict the association between blood cadmium levels and hypertension. 2024 May 27;8(4):336-344. (IF: 0)
•******** Han, ******* Mukherjee, ******** Park, ***** Lee, ***** Lee, **** Kim, ****** Lee, ****** Song, ******* Lee, ******* Bae, ********* Im. Regulation of Betaine Homocysteine Methyltransferase by Liver Receptor Homolog-1 in the Methionine Cycle. 2024 May 28;44:245. (IF: 3.168)
•****** Lee, ******* Woo, ******* Seo, ******** Lee, ********* Kim, ********* Chang, ***** Cho, ******** Yook, ***** Nam, ******* Kwon. Non-canonical deubiquitination of OTUB1 induces IFNγ-mediated cell cycle arrest via regulation of p27 stability. 2024 Jun;43(24):1852-1860. (IF: 6.9)
•********** Baniya, ****** Kim, ******** Chun. Terfenadine, a histamine H1 receptor antagonist, induces apoptosis by suppressing STAT3 signaling in human colorectal cancer HCT116 cells. 2024 Jun 13:15:1418266. (IF: 5.1)
•************* Dang, ****** Duwa, ******* Lee, ******* Kwon, ******* Chang, ******* Jeong, ******** Yook. Targeting tumor-associated macrophages with mannosylated nanotherapeutics delivering TLR7/8 agonist enhances cancer immunotherapy. 2024 Aug:372:587-608. (IF: 3.168)
•******** Joo, ******** Chun. Therapeutic strategies for colorectal cancer: antitumor efficacy of dopamine D2 receptor antagonists. 2024 Aug 7;40(4):533-540. (IF: 1.9)
•****** Duwa, ****** Choi, ******* Shrestha, ********** Nguyen, ******* Bastatas, ******** Gwon, ****** Park, ******* Jeong, ******** Yook. Strengthened binding affinity of bispecific antibody nanoplatforms improved the anti-tumor efficacy. 2024 Aug 15; 494:153128. (IF: 13.4)
•****** Sim, ******* Son, ****** Gupta, ********* Jeong, ******* Choi, ****** Han, ****** Ramos, ********* Kim, ****** Park, ***** Yoo, ******** Yoo, ****** Chang, ****** Mun, ******* Seo, ******* Kim. Development of Hsp90 inhibitor to regulate cytokine storms in excessive delayed- and acute inflammation. 2024 Aug 20:137:112470. (IF: 5.502)
•***** Sim, ********* Jang, ******** Choi, ******** Chun. Domperidone, a Dopamine Receptor D2 Antagonist, Induces Apoptosis by Inhibiting the ERK/STAT3-Mediated Pathway in Human Colon Cancer HCT116 Cells. 2024 Sep 1;32(5):568-576. (IF: 3.0)
•********** Baniya, ****** Duwa, ******* Shrestha, ******* Chang, ******** Chun & ******** Yook. AICAR-loaded and panitumumab conjugated nanoparticles downregulate the expression of PD-L1 and enhance antitumor responses against ovarian cancer through the AMPK/STAT3 axis. 2024 Sep 16;55:283-302. (IF: 5.3)
•******** Song, **** Kim, ****** Jang, ***** Ryu, ****** Jeong, ******* Lee. Exploring the progression of drug dependence in a methamphetamine self-administration rat model through targeted and non-targeted metabolomics analyses. 2024 Sep 29;14(1):22543. (IF:3.834)
•******** Chun, ****** Kim, ***** Kim, ******* Song, ***** Kim, ******** Na, ********* Surh. Targeting cyclooxygenase-2 for chemoprevention of inflammation-associated intestinal carcinogenesis: An update. 2024 Oct:228:116259. (IF: 6.1)
•********* Dang, ****** Choi, ****** Lee, ****** Lim, ****** Kwon, ****** Park. Exploiting mechanoregulation via FAK/YAP to overcome platinum resistance in ovarian cancer. 2024 Oct:179:117335. (IF: 6.9)
•******* Shrestha, ****** Duwa, ****** Lee, ******* Kwon, ******* Jeong, ******** Yook. ROS-responsive thioketal nanoparticles delivering system for targeted ulcerative colitis therapy with potent HDAC6 inhibitor, tubastatin A. 2024 Oct 1:201:106856. (IF: 4.273)
•***** Kim, Hyejin Park. Influence of Osteoporosis on Blood Lead Levels in Postmenopausal Korean Women. 2024 Nov;53(11):2602-2604. (IF: 1.3)
•******** Lamichhane, ***** Seo, ****** Jeong, ******* Lee, ******* Lee. Ideal animal models according to multifaceted mechanisms and peculiarities in neurological disorders: present and challenges. 2025 Jan;48(1):62-88. (IF: 6.898)
•******** Pham, ******* Khanal, ****** Bohara, ****** Rimal, ******** Song, ********** Nguyen, ***** Hong, ******** Cho, ******* Kang, ******* Lee, ********* Choi, ******** Yook. HDAC6 inhibitor-loaded brain-targeted nanocarrier-mediated neuroprotection in methamphetamine-driven Parkinson's disease. 2025 Feb:79:103457. (IF: 10.697)